Skip to main content


Figure 2 | BMC Medicine

Figure 2

From: Tissue-derived mesenchymal stromal cells used as vehicles for anti-tumor therapy exert different in vivoeffects on migration capacity and tumor growth

Figure 2

In vivo xenograft imaging of mice using a magnetic resonance labeling (MRI) scanner. Scans were performed at 3, 10, 17, and 24 days after intravenous injection of super-paramagnetic iron oxide (SPIO)-labeled mesenchymal stem cells (MSCs). Tumors were visible as lighter areas in transverse sections. The recruitment of SPIO-labeled MSCs to tumors resulted in decrease of signal intensity (SI) and the visualization of darker areas in tumor sites. The same animals are represented over the entire period.

Back to article page